Eric Snyder, MD, PhD

Associate Professor, University of Utah School of Medicine

Education

• Doctorate Degree—Molecular/Cellular Biology, Washington University
• Medical Degree—Washington University
• Residency—Anatomic Pathology, Brigham and Women’s Hospital
• Postdoctoral Research Fellowship—Massachusetts Institute of Technology

Certifications/Affiliations

• American Board of Pathology (Anatomic Pathology)

Research Interests

• Mouse models of cancer
• Lung cancer
• Pancreatic cancer
• Transcription factors

Awards

• Burroughs Wellcome Career Award for Medical Scientists, 2011
• Pathobiology Prize, United States and Canadian Academy of Pathology, 2009

Recent Publications

• Camolotto, SA, Belova VK, Torre-Healy L, et al. Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4. Gut. 2021;70(5):900-914.
• Kinsey CG, Camolotto SA, Boespflug AM, et al. Protective autophagy elicited by RAF→ MEK→ ERK inhibition suggests a treatment strategy for RAS-driven cancers [published correction appears in Nat Med. 2019;25(5):861]. Nat Med. 2019;25(4):620-627.
• Camolotto SA, Pattabiraman S, Mosbruger TL, et al. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer. Elife. 2018;7:338579.
• Caswell DR, Chuang CH, Ma RK, et al. Tumor suppressor activity of Selenbp1, a direct Nkx2-1 target, in lung adenocarcinoma. Mol Cancer Res. 2018;16(11):1737-1749.
• Mollaoglu G, Jones A, Wait SJ, et al. The lineage-defining transcription factors SOX₂ and NKX_2-1 determine lung cancer cell fate and shape the tumor immune microenvironment. Immunity. 2018;49(4):764-779.e9.